Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Jervois Global Ord Shs V.JRV

Alternate Symbol(s):  JRVMF

Jervois Global Limited is an Australia-based supplier of cobalt and nickel, serving both the battery and chemicals markets. The Company's segments include Australia, Brazil, Finland, United States and Other. The Australia segment includes Nico Young and other Australian tenement licenses held. The Brazil segment includes the Sao Miguel Paulista nickel and cobalt refinery (SMP Refinery). The Finland segment includes the cobalt refining and specialty products business located in Kokkola, Finland. Its product categories include chemical and catalysts, pigments, powder metallurgy and battery. The United States segment includes the Idaho Cobalt Operations (ICO) cobalt-copper-gold mine in Lemhi County outside of the town of Salmon, Idaho. The Other segment consists of non-core exploration not related to Australia and the United States. The Company's non-core assets are located in Canada (Virgin River project and Kernahan/Bell project) and Australia (Arunta West project).


TSXV:JRV - Post by User

Comment by Justhalffullon Nov 16, 2021 8:39am
71 Views
Post# 34130794

RE:RE:Interesting

RE:RE:InterestingYou fail to do any research.  mRNA vaccines have been in research since the 80's.  The only difference in the Covid vaccine is the spike protein that is created.
The messenger RNA vaccine instructs the body how to create a spike protein.  This spike protein is found on the surface of the Covid 19 virus.
The body then breaks down the mRNA and removes it.  The immune system creates antibodies to attach the spike protein, and it is this immune response and antibodies your body now has that attacks the actual virus should you become infected.   This is why new vaccines can be created quickly.  They are all similar, it is just the spiike protein that you want the body to create that is different.  And the risk of catching the virus from the vaccine becomes non existent.
<< Previous
Bullboard Posts
Next >>